Shekhat Denil Nanji Purchases 50,000 Shares of MIRA

On June 12, 2026, insider Shekhat Denil Nanji bought 50,000 shares of MIRA. This transaction was not part of a pre-planned trading program. The shares were acquired at a time when MIRA stock was trading at approximately $0.9319.

Insider Buying and Selling at MIRA Pharmaceuticals, Inc.

Several insiders have been active in acquiring MIRA shares. On the same day as Nanji's purchase, other insiders, including Edward Clouston Macpherson, Matthew Paul Del Giudice, and Matthew Pratt Whalen, each acquired 50,000 shares. Earlier, on December 17, 2025, CEO and Chairman Erez Aminov made a significant purchase of 3,155,170 shares.

Other Institutional Activity in MIRA

Institutional investors have also shown interest in MIRA. Vanguard Capital Management LLC increased its holdings by 693,912 shares, now holding 693,912 shares valued at about $742,486. Geode Capital Management, LLC added 18,012 shares, bringing its total to 290,890 shares worth approximately $311,251. Meanwhile, BlackRock, Inc. slightly increased its stake by 2,577 shares, ending with 112,346 shares valued at $120,210. Conversely, Suncoast Equity Management reduced its position by 12,644 shares, leaving it with 90,645 shares worth $96,990.

Bottom Line

The recent insider purchases at MIRA, including those by Shekhat Denil Nanji and other key figures, suggest a strong interest in the company's prospects. Institutional investors have also been adjusting their positions, reflecting varied perspectives on the stock. Such insider and institutional activities are closely watched by investors looking for signals about a company's future performance.